Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty
Degenerative Osteoarthritis
About this trial
This is an interventional diagnostic trial for Degenerative Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Patients who are 18 to 79 85 years of age
- CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
- CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
- CJR patients without a previous arthroplasty procedure who have established care with our practice.
Exclusion Criteria:
- Previous history of hip infection
- Current antibiotic use or antibiotic use within the past week
- Previous history of Cutibacterium joint infection
- Current immunodeficiency disease or disorder
- Patients with active psoriatic disease or other focal inflammation over the hip
- Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)
Sites / Locations
- Colorado Joint ReplacementRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Standard Skin Prep
Experimental Skin Prep with BPO
Patients will undergo a skin cleansing protocols using 4% Chlorhexidine gluconate (CHG) cloths. After the skin prep, three 3-mm punch (Acu-Punch, Acuderm, Fort Lauderdale, FL) skin biopsies will performed for both an anterior-based hypothetical incision, and for a more lateral/posterior incision, for a total of 6 biopsies taken per subject.
Patients will undergo a skin cleansing protocols using 4% Chlorhexidine gluconate (CHG) cloths. Following the CHG wipes, patients will be prepped with 5% BPO gel applied directly to the biopsy site. After the skin prep, three 3-mm punch (Acu-Punch, Acuderm, Fort Lauderdale, FL) skin biopsies will performed for both an anterior-based hypothetical incision, and for a more lateral/posterior incision, for a total of 6 biopsies taken per subject.